Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 23

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 23
---
 Weiler was appointed as our Chief Financial Officer on April 3, 2025, effective May 1, 2025. Since August 2018, Mr. Weiler served as President of Exzell Pharma, Inc., a privately held, commercial-stage pharmaceutical company. From August 2017 to August 2018, Mr. Weiler served as Vice President of Business Development at Biosyent Inc. (TSX: RX). Prior to that, he served in various roles at Cipher Pharmaceuticals Inc. (TSX: CPH), including Vice President of Business Development from January 2015 to June 2017, Senior Director from January 2012 to January 2014, and Director from December 2008 to December 2011. Prior to Cipher, he served as Senior Director of Investment Analysis at DRI Capital Inc. and held research and financial positions at Eli Lilly Canada Inc. Mr. Weiler holds a Master of Business Administration degree from the Ivey School of Business, University of Western Ontario, a Masters of Science in Biology degree from the University of Western Ontario, and a Bachelor of Science (Honors Biology) degree and Diploma in Accounting from Wilfrid Laurier University.

<div align='center'>14

EXECUTIVE COMPENSATION</div>

Summary Compensation Table

The following table sets forth information regarding the compensation awarded to, earned by or paid to the named executive officers for the years ended September 30, 2023 and September 30, 2022.

| Name and Principal Position                               |     | Fiscal Year |     | Salary ($) |         |    |     | Bonus ($) |        |    |     | Stock          
 Awards ($) (1) |        |    |     | Options        
 Awards ($) (1) |        |     | All Other Compensation ($) |        |    |     | Total ($) |         |
|:----------------------------------------------------------|:----|------------:|:----|:-----------|--------:|---:|:----|:----------|-------:|---:|:----|:---------------|-------:|---:|:----|:---------------|-------:|:----|:---------------------------|-------:|---:|:----|:----------|--------:|
| Pardeep Nijhawan, MD                                      |     |        2024 |     | $          | 357,696 | -2 |     | $         | 72,434 |    |     | $              |      - |    |